Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Found 4633 publications
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry... US$ 3,400.00

“GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline Analysis)” by Kelly Scientific Publications is a comprehensive report on the cancer biomarker industry and ...

May, 2014 232 pages
Global In-vitro Toxicity  Testing Market 2014-2018 US$ 2,500.00

... , and skin corrosion/irritation. TechNavio's analysts forecast the Global In Vitro Toxicity Testing market will grow at a CAGR of 15.84 percent over the period 2013 ... and a corresponding detailed analysis of the top four vendors in the market. In addition, the report discusses the major drivers that influence ...

Apr, 2014 71 pages
In-Vitro Diagnostics Market Outlook 2018 US$ 1,700.00

... coming years. In the latest research study, “In-Vitro Diagnostics Market Outlook 2018”, RNCOS analysts identified market dynamics in various important regions to highlight ... and Player specializations, and for every segment a current and future outlook to 2018 has been provided. For regional analysis, key IVD ...

Apr, 2014 145 pages
2014 Innovative Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Technologies, and Their Market Applications US$ 2,850.00

The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. Contains ...

Apr, 2014 197 pages
Emerging Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Companies Developing New Technologies and Products US$ 3,850.00

The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. Contains ...

Apr, 2014 197 pages
2014 Analysis of Molecular and Immunohematology Blood Banking Technologies, and Strategic Profiles of Leading Suppliers US$ 3,850.00

This 154-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and ...

Apr, 2014 154 pages
2014 Analysis of Molecular and Immunohematology Blood Banking Instrumentation, and Strategic Profiles of Leading Suppliers US$ 3,850.00

This 111-page report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers. The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, ...

Apr, 2014 111 pages
2014 Analysis of Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Strategic Profiles of Leading Suppliers US$ 3,850.00

This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. ...

Apr, 2014 280 pages
2014 US Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies US$ 9,700.00

... and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and ... Blood Banks Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated ...

Apr, 2014 465 pages
2014 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies US$ 6,100.00

... potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated ...

Apr, 2014 430 pages
2014 Spain Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies US$ 6,100.00

... market entrants identify and evaluate emerging opportunities in the Spanish molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated and ...

Apr, 2014 425 pages
2014 Japan Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies US$ 7,700.00

... market entrants identify and evaluate emerging opportunities in the Japanese molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated and ...

Apr, 2014 430 pages
2014 Italy Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies US$ 6,100.00

... market entrants identify and evaluate emerging opportunities in the Italian molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated and ...

Apr, 2014 430 pages
2014 Germany Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies US$ 6,100.00

... market entrants identify and evaluate emerging opportunities in the German molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated and ...

Apr, 2014 430 pages
2014 France Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies US$ 6,100.00

... market entrants identify and evaluate emerging opportunities in the French molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated and ...

Apr, 2014 435 pages
2014 European Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Spain, UK--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive... US$ 19,700.00

... market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and ... , by test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...

Apr, 2014 630 pages
2014 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Japan, Spain, UK, US--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive... US$ 34,500.00

... market entrants identify and evaluate emerging opportunities in the global molecular blood banking market during the next five years, and ... by country. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...

Apr, 2014 775 pages
In-Vitro Toxicology/ Toxicity Testing Market by Industry (Diagnostic, Pharmaceutical, Cosmetics, Chemical), Technology (Cell Culture, HTS, Omics), Applications (Systemic, Dermal, Ocular),... US$ 4,650.00

... silico techniques. Pharmaceutical industry was the largest segment in the in vitro toxicology testing market which is expected to hold the leading position in the ... penetration, skin irritation/corrosion and skin sensitization under dermal toxicity. This was later clarified with the help of various experts ...

Apr, 2014 246 pages
Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Neuroendocrine Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 124 pages
Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the... US$ 4,650.00

... global POC diagnostics market in 2013, followed by Asia-Pacific. A number of factors such as increase in waiver of CLIA for certain point of care diagnostic tests, ... portfolio offered by the top players in the POC diagnostics market. The report analyzes the products market by category/end user across geographies ...

Mar, 2014 452 pages
Market Research Report on Global and Chinese Scanning Electron Microscope (SEM) Industry, 2009-2019 US$ 2,400.00

... Electron Microscope (SEM) Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Scanning Electron Microscope (SEM) industry. ... analyzes the upstream raw materials, downstream clients, and current market dynamics of Scanning Electron Microscope (SEM) Industry. In the end, the ...

Mar, 2014 150 pages
Market Research Report on Global and Chinese In Vitro Diagnostics Industry, 2009-2019 US$ 2,400.00

... economic parameters of each company; The breakdown data of In Vitro Diagnostics market are presented by company, by country, and by application; The report also ... analyzes the upstream raw materials, downstream clients, and current market dynamics of In Vitro Diagnostics Industry. In the end, the report makes ...

Mar, 2014 150 pages
Market Research Report on Global and Chinese Diagnostic reagent filling linkage production line Industry, 2009-2019 US$ 2,400.00

... filling linkage production line Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Diagnostic reagent filling linkage production ... line listing their product specification, capacity, Production value, and market share etc.; The report further analyzes quantitatively 2009-2014 ...

Mar, 2014 150 pages
Market Research Report on Global and Chinese Coagulation Analyzer Industry, 2009-2019 US$ 2,400.00

... economic parameters of each company; The breakdown data of Coagulation Analyzer market are presented by company, by country, and by application; The report also ... analyzes the upstream raw materials, downstream clients, and current market dynamics of Coagulation Analyzer Industry. In the end, the report makes ...

Mar, 2014 150 pages
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide US$ 1,490.00

... are as follows 1. United Kingdom 2. France 3. Germany 4. Italy 5. Spain 6. Sweden 7. Switzerland 8. Norway 9. Netherlands 10. United States 11. Canada 12. Japan 13. Korea 14. Singapore 15. Malaysia 16. Australia 17. India 18. China 19. Thailand 20. Indonesia Data Sources This report is built using data ...

Apr, 2014 232 pages
Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018 US$ 2,150.00

Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018 mainly conducts in-depth analysis on the external environment, market operation, import & export of China’s IVD reagent industry, and also summaries the latest development of key Chinese ...

Feb, 2014 90 pages
Penile Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Penile Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Mar, 2014 69 pages
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 US$ 5,995.00

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the highest unmet need in oncology. This report focuses on the current treatment landscape, unmet needs, ...

Mar, 2014 179 pages
Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Nasopharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 81 pages
Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014" provides data on the Hormone-Sensitive Prostate Cancer clinical trial scenario. This report provides elemental information and data ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 84 pages
Global In Vitro Fertilization (IVF) Market (Instruments, Reagents and Media, Technology, Geography) - Size, Share, Trends, Opportunities, Global Demand, Insights, Analysis, Research,... US$ 4,515.00

... vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and ... can be created through medical tourism and availability of low cost IVF treatments. The companies profiled in this report include Vitrolife AB, Cooper ...

Jan, 2014 106 pages
Cancer Stem Cell Trends: Market Research Report US$ 1,450.00

The report illustrates on the growing market for Cancer Stem Cells (CSCs) in the US and Europe The major factors stimulating the growth of ... from several human tumors such as brain, breast, colon and haematopoietic cancers. CSCs are believed to survive in tumors as a completely distinct population and might ...

Jan, 2014 23 pages
Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment - KOL Insight US$ 4,995.00

... of NSCLC treatments, development and competition, KOL Insight: Non-small cell lung cancer is an essential tool for keeping abreast of events that will ... of the Aerodigestive Oncology Translational Research THOR Cleveland Clinic Taussig Cancer Center, Ohio, USA. Dr Joan Shiller, deputy director of the Simmons ...

Mar, 2014 134 pages
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update US$ 9,995.00

... the use of combination therapies and novel branded drugs. With the recent therapeutic guidelines putting emphasis on a patient-tailored approach in treating type 2 diabetes, pharmaceutical companies will achieve considerable success with their me-too drugs. In the future, companies will have to shift their ...

Jan, 2014 465 pages
PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022 US$ 9,995.00

... ) and due to the uptake of one novel branded drug for diabetic nephropathy. Highlights Key Questions Answered None of the current therapies ... but potentially very lucrative market? The diagnosed prevalence of microvascular complications of diabetes in the world dangerously increased in the past 10 years and ...

Dec, 2013 367 pages
Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014' provides data on the Papillary Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 91 pages
Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Human papillomavirus (HPV) Associated Cancer clinical trial scenario. This report provides elemental information and ... in each, along with the clinical trial scenario in BRIC nations Clinical trial (complete and in progress) data by phase, trial status, subjects ...

Mar, 2014 121 pages
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014' provides data on the Hormone Sensitive Breast Cancer clinical trial scenario. This report provides elemental information and data ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Mar, 2014 170 pages
Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014' provides data on the Hormone Refractory Breast Cancer clinical trial scenario. This report provides elemental information and data ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 123 pages
The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ US$ 1,350.00

... the industry leaders are doing TODAY Within GMR Data’s 'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ we analyse the key ... and secondary research sources, GMR Data have interviewed leading cancer specialists within big pharma, R&D, wholesalers, distributors, marketeers and key ...

Nov, 2013 243 pages
In Vitro Fertilization Market in Asia Pacific - Country Analysis by End Users (Clinics, Hospitals, Surgical Centers, Clinical Research Institutes, Banks) Number of Cycles, Revenue, Market... US$ 5,315.00

... and trends towards financial stability. The Asia Pacific IVF market, valued at $1.3 billion in 2012, is estimated to reach $4.2 billion by 2020. Delayed pregnancy ... driving factors of the IVF market are rise in infertility rate due to rise in stress levels, change in life style and fertility related diseases. ...

Mar, 2014 155 pages
Head and Neck Cancer Partnering 2009-2014 US$ 995.00

... and neck cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license ... access to the contract. Chapter 4 provides a comprehensive directory of head and neck cancer partnering deals signed and announced since 2009. The ...

Mar, 2014 150 pages
Diagnostics Deals and Alliances of 2013 US$ 1,495.00

The Diagnostics Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered ... , signed by bigpharma and bigbiotech, and most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online ...

Mar, 2014 200 pages
Companion Diagnostics Deals and Alliances of 2013 US$ 1,495.00

The Companion Diagnostics Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements ... signed by bigpharma and bigbiotech, and most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online ...

Mar, 2014 200 pages
Cardiovascular Deals and Alliances of 2013 US$ 1,495.00

The Cardiovascular Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered ... signed by bigpharma and bigbiotech, and most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online ...

Mar, 2014 200 pages
Prenatal and New-born Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 US$ 4,795.00

... the sex of the fetus. Prenatal and newborn genetic testing is referred to as the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect ... the year 2012, followed by a list of recommendations for the existing and new players to enter and enhance their market shares. The report ...

Mar, 2014 87 pages
Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, Low Density Multiplexed Assays & Next-Generation Sequencing; Applications: Infectious Disease Diagnosis, Oncology,... US$ 4,795.00

... report for the period 2011 to 2019. This report also includes the overall market growth rate (Compounded Annual Growth Rate) ... , Inc. The global multiplexed diagnostics market is segmented as follows: Multiplexed Diagnostics Market, by Technology Very high density multiplexed assays Oligonucleotide Arrays ...

Mar, 2014 102 pages
Cancer Gene Therapy Market Analysis US$ 1,800.00

... clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus ... Involved with Application of Gene Therapy in Cancer Patients Regulatory Scenario for Gene Therapy Market Cancer Gene Therapy Drug Clinical Trial ...

Mar, 2014 300 pages
Hypopharyngeal Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Hypopharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Feb, 2014 115 pages
Gastrointestinal Tract Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014' provides data on the Gastrointestinal Tract Cancer clinical trial scenario. This report provides elemental information and data relating ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Mar, 2014 413 pages
1 2 3 4 5 >
Skip to top